Macular hole closure following anti-vascular endothelial growth factor injection in an eye with myopic choroidal neovascularization

被引：0

作者：

Cheolmin Yun ^{[1
]}

Seong-Woo Kim ^{[1
]}

Kuhl Huh ^{[1
]}

Jaeryung Oh ^{[1
]}

机构：

[1] Department of Ophthalmology,Korea University College of Medicine

来源：

International Journal of Ophthalmology | 2016年 / 09期

关键词：

CNV; Macular hole closure following anti-vascular endothelial growth factor injection in an eye with myopic choroidal neovascularization;

D O I：

暂无

中图分类号：

R774.5 [黄斑、中心窝疾病];

学科分类号：

100212 ;

摘要：

Dear Editor,I am Cheolmin Yun,from the Department of Ophthalmology,Korea University College of Medicine.I write to present a case report of a female patient with a myopic patient suffering from atrophic choroidal neovascularization(CNV)and a full thickness macular hole(FTMH),who was treated with an intravitreal anti-vascular

引用

页码：1364 / 1366

页数：3

共 50 条

[11] Subfoveal Fibrosis and Visual Outcome in Myopic Choroidal Neovascularization Treated with Anti-vascular Endothelial Growth Factor
Ahn, Seong Joon
Woo, Se Joon
Park, Kyu Hyung
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[12] Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization
Chien-Jung Huang
Yun Hsia
Shih-Wen Wang
I.-Hsin Ma
Mei-Chi Tsui
Kuo-Chi Hung
Tzyy-Chang Ho
Scientific Reports, 13
[13] Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
Ruparelia, Sunil
Sundaram, Aishwarya
Dahrab, Mishari
Symonds, Chris
Cruess, Alan
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
[14] Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Due to Sorsby Macular Dystrophy
Kapoor, Kapil G.
Bakri, Sophie J.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (04) : 444 - 447
[15] The use of anti-vascular endothelial growth factor therapies in the macular telangiectasia associated with choroidal neovascularization.
Abdelaziz, Musa
Rostamizadeh, Mahdi
Schartman, Jerome
Zegarra, Hernando
Zakov, Z. Nicholas
Novak, Michael
Pendergast, Scott
Coney, Joseph
Singerman, Lawrence J.
Miller, David
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[16] Anti-Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization: Do We Need More Evidence?
Lai, Timothy Y. Y.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1443 - 1445
[17] Factors associated with visual outcome after anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization
Minami, Sakiko
Uchida, Atsuro
Mushiga, Yasuaki
Nagai, Norihiro
Suzuki, Misa
Watanabe, Kazuhiro
Sonobe, Hideki
Kurihara, Toshihide
Shinoda, Hajime
Tsubota, Kazuo
Ozawa, Yoko
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
[18] FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION
Iacono, Pierluigi
Parodi, Maurizio Battaglia
Selvi, Federico
Parravano, Maria Cristina
Chiaravalloti, Adele
Varano, Monica
Bandello, Francesco
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1931 - 1941
[19] The other CNVM: A review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents
Adatia, Feisal A.
Luong, Micah
Munro, Monique
Tufail, Adnan
SURVEY OF OPHTHALMOLOGY, 2015, 60 (03) : 204 - 215
[20] Distribution of recurrence time intervals after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
Takao-Okuma, Hiroko
Terao, Ryo
Nagahara, Masako
Azuma, Keiko
Inoue, Tatsuya
Uemura, Yukari
Obata, Ryo
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2021, 56 (02): : 137 - 138

← 1 2 3 4 5 →